Immunoadsorption for the treatment of narcolepsy with cataplexy

Neurological Sciences

Volumn 29, Issue 6, 2008, Pages 499-500

  Pincherle, Alessandro ^a   Villani, Flavio ^a   Ferini Strambi, Luigi ^b   Livia Fantini, Maria ^b   Dylgjeri, Suela ^a   Spreafico, Roberto ^a   Antozzi, Carlo ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN; IMMUNOGLOBULIN G;

ADULT; CASE REPORT; CATAPLEXY; DISEASE DURATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; HUMAN; IMMUNOADSORPTION; LETTER; NARCOLEPSY; PATIENT SAFETY; POLYSOMNOGRAPHY; QUESTIONNAIRE; THERAPY EFFECT;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOTHERAPY; NARCOLEPSY; SLEEP; TREATMENT OUTCOME;

EID: 58149097005     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-1036-9     Document Type: Letter

References (15)

1. International Classification of Sleep Disorders (ICSD) (1990) Diagnostic and Coding Diagnostic Classification Steering Committee (Thorpy MJ, chairman). American Sleep Disorders Association. Narcolepsy 347:38-43
2. Mignot E, Lin L, Rogers W et al (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68:686-699
3. Smith AJ, Jackson MW, Neufing P et al (2004) A functional autoantibody in narcolepsy. Lancet 364:2122-2124
4. Knudsen S, Mikkelsen JD, Jennum P (2007) Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons. Neuroreport 18:77-79
5. Billiard M, Bassetti C, Dauvilliers Y et al (2006) EFNS guidelines on management of narcolepsy. Eur J Neurol 13:1035-1048
6. Hecht M, Lin L, Kushida CA et al (2003) Report of a case of immunosuppression with prednisone in 8-year-old boy with an acute onset of hypocretin deficiency narcolepsy. Sleep 26:809-810
7. Lecendreux M, Maret S, Bassetti C et al (2003) Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 12:347-348
8. Dauvilliers Y, Carlander B, Rivier F et al (2004) Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 56:905-908
9. Dauvilliers Y (2006) Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol 60:153
10. Chen W, Black J, Call P et al (2005) Late-onset narcolepsy presenting as rapidly progressing muscle weakness: Response to plasmapheresis. Ann Neurol 58:489-490
11. Fronczek R, Verschuuren J, Lammers GJ (2007) Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol 254:1607-1608
12. Hershko AY, Naparstek Y (2005) Removal of pathogenic autoantibodies by immunoadsorption. Ann NY Acad Sci 1051:635-646
13. Antozzi C, Frassoni C, Vincent A et al (2005) Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology 64:1290-1293
14. Terzano MG, Parrino L, Smerieri A et al (2002) Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med 3:187-199
15. Morrish E, King MA, Smith IE et al (2004) Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 5:37-41